Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration.
Jens Ivar Brox, Roger Sørensen, Astrid Friis...
https://pubmed.ncbi.nlm.nih.gov/12973134/Actively Recruiting
Led by Oslo University Hospital · Updated on 2026-03-17
202
Participants Needed
5
Research Sites
8 weeks
Total Duration
Researchers are comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation to find out which is better at relieving persistent low back pain lasting at least one year in adults aged 20 to 65 years. Chronic low back pain is a leading cause of disability worldwide, with complex causes and limited effective treatments. This study aims to provide clearer evidence on treatment effects and explore new ways to diagnose and tailor treatments using advanced imaging and biomarkers. Participants will be randomly assigned to either lumbar interbody fusion surgery or a multidisciplinary rehabilitation program. The surgery involves fusion of one or two lumbar spine levels through either a transforaminal lumbar interbody fusion TLIF or anterior lumbar interbody fusion ALIF procedure, including stabilization with screws. The rehabilitation consists of 2.5 to 5-hour sessions, 2 to 4 days per week, for 3 to 5 weeks, focusing on cognitive and physical therapy guided by specialists. Both groups will undergo detailed imaging, blood tests, and activity monitoring throughout the study. Participants will provide information about their pain, disability, physical activity, and sleep patterns at several points during the study using questionnaires and accelerometers. Blood samples and imaging will be collected at baseline and follow-ups to assess biomarkers. Safety and adverse events will be closely monitored, especially for surgery participants, with clinical exams, blood tests, and scans. The main measure is the change in disability at one year, with additional evaluations up to two years. The study also assesses cost-effectiveness and quality of life impact over the follow-up period.
CONDITIONS
The Lumbar Interbody Fusion vs. Multidisciplinary Rehabilitation (LIFEHAB) Trial
S
Sverre Mjønes, MD
K
Kjersti Storheim, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Oslo University Hospital
Lead Sponsor
University Hospital, Akershus
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 to 2 visits including assessments by two different surgeons and necessary imaging examinations (MRI and X-ray) before treatment initiation
Duration - Treatment initiation within 3 months of randomization; active treatment period varies per individual
Participants randomized to this group undergo lumbar interbody fusion surgery involving one or two lumbar levels with stabilization using screws, followed by monitoring for surgical outcomes and adverse events.
1 surgery visit followed by multiple post-operative clinical examinations, blood sample analyses, and radiologic imaging visits
Duration - 3 to 5 weeks of outpatient rehabilitation
Participants randomized to this group receive outpatient multidisciplinary rehabilitation consisting of cognitive therapy and supervised physical and functional training over a period of 3 to 5 weeks.
Multiple sessions 2-4 days per week, each lasting 2.5 to 5 hours
Duration - Up to 2 years, with key assessments at 6, 12, and 24 months
Participants in both groups are followed up to evaluate treatment effectiveness and monitor adverse events, including collection of clinical data, biomarker samples, and questionnaires.
Scheduled follow-up visits at baseline, 6 months, 12 months, and 24 months including blood sample collections and clinical assessments
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jens Ivar Brox, Roger Sørensen, Astrid Friis...
https://pubmed.ncbi.nlm.nih.gov/12973134/Kathryn T Weber, D Olivier Alipui, Cristina P Sison...
https://pubmed.ncbi.nlm.nih.gov/26743937/Maxim Bez, Zhengwei Zhou, Dmitriy Sheyn...
https://pubmed.ncbi.nlm.nih.gov/30478330/H B Albert, P Kjaer, T S Jensen...
https://pubmed.ncbi.nlm.nih.gov/17624684/Hanne B Albert, Joan S Sorensen, Berit Schiott Christensen...
https://pubmed.ncbi.nlm.nih.gov/23404353/Akihiko Hiyama, Kaori Suyama, Daisuke Sakai...
https://pubmed.ncbi.nlm.nih.gov/34191345/Jeremy Fairbank, Helen Frost, James Wilson-MacDonald...
https://pubmed.ncbi.nlm.nih.gov/15911537/Jan Hartvigsen, Mark J Hancock, Alice Kongsted...
https://pubmed.ncbi.nlm.nih.gov/29573870/Lars Christian Haugli Bråten, Mads Peder Rolfsen, Ansgar Espeland...
https://pubmed.ncbi.nlm.nih.gov/31619437/Federico Balagué, Anne F Mannion, Ferran Pellisé...
https://pubmed.ncbi.nlm.nih.gov/21982256/Oslo University Hospital
Lead Sponsor
University Hospital, Akershus
Collaborating Sponsor